Exposição profissional histórica documentada ao benzeno num indivíduo sem corrente...
Visão determinística da entidade fonte YAML. A autoridade clínica permanece com os IDs de fonte citados e estado de assinatura do revisor.
| ID | RF-OCC-BENZENE-MALIGNANCY-PREVENTION |
|---|---|
| Tipo | Sinal de alerta |
| Estado | reviewed 2026-05-18 | pending_clinical_signoff |
| Doenças | DIS-AML DIS-MDS-HR DIS-MDS-LR |
| Fontes | SRC-ELN-AML-2022 SRC-ESMO-MDS-2021 SRC-NCCN-AML-2025 |
Origem da bandeira vermelha
| Definição | Documented historical occupational exposure to benzene in an individual without a current myeloid neoplasm diagnosis. Classic high-exposure occupations: petroleum refining, petrochemical manufacturing, rubber / tire industry, shoemaking (cement / adhesive use pre-regulation), printing / lithography (solvent use), pharmaceutical manufacturing, coke / coal-tar industry, motor- vehicle service (fuel-pump / gasoline exposure pre-vapor-recovery), laboratory work with benzene solvent (largely historical). Benzene is an IARC Group 1 carcinogen with the strongest hematopoietic- malignancy linkage of any non-radiation occupational exposure — established etiological driver of acute myeloid leukemia (especially AML with cytogenetic abnormalities of chromosomes 5, 7, 8; monosomy 7), myelodysplastic syndromes (low- and high-risk MDS subtypes both elevated), and acute lymphoblastic leukemia (smaller... |
|---|---|
| Direcção clínica | investigar |
| Categoria | Outros |
Lógica de Desencadeamento
{
"any_of": [
{
"finding": "occupational_benzene_exposure_documented",
"value": true
},
{
"finding": "occupational_benzene_exposure_years_ge_5",
"value": true
},
{
"finding": "occupational_petroleum_refining_or_solvent_industry",
"value": true
}
],
"type": "lab_value"
}
Notas
Prevention-persona RedFlag — v0.3 occupational pilot starter. Fires when patient profile carries documented prior occupational benzene exposure AND no confirmed myeloid neoplasm diagnosis. Engine routes such patients to a 2-track PreventionPlan: (a) IND-OCC-BENZENE-PREVENTION-INTENSIFIED-SURVEILLANCE (standard) — exposure-cessation counseling (if active), CBC q6-12 months with peripheral smear review for cytopenias, low-threshold bone marrow evaluation for persistent cytopenia (>3-6 months) or unexplained macrocytic anemia, co-management with hematology if any abnormality emerges. (b) IND-OCC-BENZENE-PREVENTION-OBSERVATION (surveillance) — symptom-triggered evaluation only; patient declines routine CBC surveillance for any reason. Evidence base (IARC Monograph 100F 2012; Vlaanderen et al. 2011 systematic review; Khalade et al. 2010 meta-analysis; Pulmonary Industry cohort studies eg, Pliofilm cohort Rinsky et al. 1987; Chinese cohort Hayes et al. 1997): - AML SMR ~2-3x in moderately exposed cohorts (cumulative dose ~40 ppm-years); ~10x in heavily exposed cohorts. Dose-response established at exposures >40 ppm-years. - MDS SMR ~2-4x; benzene-attributable MDS frequently progresses t...
Usado por
Indicação
IND-OCC-BENZENE-PREVENTION-INTENSIFIED-SURVEILLANCE- IND-OCC-BENZENE-PREVENTION-INTENSIFIED-SURVEILLANCEIND-OCC-BENZENE-PREVENTION-OBSERVATION- IND-OCC-BENZENE-PREVENTION-OBSERVATION